{"id":84850,"date":"2025-09-08T11:33:56","date_gmt":"2025-09-08T16:33:56","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/argomento-gestione-del-diabete-insipido-di\/"},"modified":"2025-09-18T14:17:16","modified_gmt":"2025-09-18T19:17:16","slug":"argomento-gestione-del-diabete-insipido-di","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/it\/argomento-gestione-del-diabete-insipido-di\/","title":{"rendered":"Gestione del diabete insipido (DI)"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"Managing Diabetes Insipidus (AVP-D): Practical Guidance from a Patient-Expert\" width=\"1080\" height=\"608\" src=\"https:\/\/www.youtube.com\/embed\/qash_2MFo1Q?feature=oembed\"  allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p>Pat Gildroy, amministratrice del gruppo Facebook &#8220;Got Arginine VasoPressin Deficiency?&#8221;, parla delle risorse, dei sintomi, dei test e dell&#8217;esperienza dei pazienti affetti da deficit di arginina vasopressina, precedentemente noto come diabete insipido.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La gestione del diabete insipido (DI), ora chiamato deficit di arginina vasopressina (AVP-D), \u00e8 fondamentale per i pazienti, le famiglie e i medici, soprattutto per quelli affetti da malattia di Erdheim-Chester (ECD) o istiocitosi a cellule di Langerhans (LCH), dove l&#8217;AVP-D \u00e8 pi\u00f9 comune.<\/p>\n","protected":false},"author":20,"featured_media":92901,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_wds_title":"","_wds_metadesc":"","_wds_focus-keywords":"","_wds_meta-robots-adv":"","_wds_meta-robots-noindex":false,"_wds_meta-robots-nofollow":false,"_wds_meta-robots-index":false,"_wds_meta-robots-follow":false,"_wds_autolinks-exclude":false,"_wds_canonical":"","_wds_redirect":"","_wds_opengraph":[],"_wds_twitter":{"disabled":true},"cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[589],"tags":[4262,4771,4775,470,2356,4270,4773,1156,457,4268,4264,2454,4263,4260,4266],"class_list":["post-84850","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-registrazioni-di-webinar","tag-collaborazione-scientifica","tag-diabete","tag-diabeteinsipido","tag-ecdga-it","tag-globalhealth-it","tag-innovazione-medica","tag-insipido-it","tag-istiocitosi","tag-malattia-di-erdheimchester","tag-oncologiaricerca","tag-registro-dei-pazienti-it","tag-ricerca-medica","tag-ricerca-sulle-malattie-rare","tag-sovvenzioneopportunita","tag-traduzione-clinica"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/posts\/84850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/comments?post=84850"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/posts\/84850\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/media\/92901"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/media?parent=84850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/categories?post=84850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/tags?post=84850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}